RIPK1 and Alzheimer disease: Furthermore, the Mini-Mental State Examination (MMSE), commonly used to assess cognitive function, showed a strong negative correlation between the expression levels of RIPK1 and MLKL and MMSE scores in AD patients, while no such correlation was observed in the control group.